VYERA PHARMACEUTICALS LLC
Business Summary
Turing Pharmaceuticals LLC (Turing) is a United States-based biopharmaceutical company focusing on patients with unmet medical needs. The Company is engaged in the discovery and development of therapies for debilitating and often life-threatening diseases, which include Vecamyl and Daraprim. The Company offers Vecamyl for hypertension and rage disorders in autism, Syntocinon-for Lactation, IN Ketamine for Suicidal Ideation, TUR-004 for orphan indication, and TUR-003 for orphan indication. The Company's pipeline products include Syntocinon-and Ketamine. The Company offers Syntocinon-in the United States for lactation and has started a development program for a range of serious medical conditions unrelated to its lactation indication. Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist.
Country of Incorporation
United States of America
Incorporation Date
2014-10-08
Business Sector
Pharmaceuticals & Medical Research
Company Address
600 3rd Ave Fl 10
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
